YIH
MD icon

Y-Intercept (HK)’s Pediatrix Medical MD Stock Holding History

Y-Intercept (HK)’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,620
Closed -$513K – 1826
2025
Q3 		$513K Buy
+30,620
New +$459K 0.01% 1250
2024
Q3 		– Sell
-32,423
Closed -$245K – 1598
2024
Q2 		$245K Buy
32,423
+14,489
+81% +$120K 0.01% 1100
2024
Q1 		$180K Sell
17,934
-154
-0.9% -$1.43K 0.01% 1185
2023
Q4 		$168K Buy
+18,088
New +$187K 0.02% 1033
2023
Q3 		– Sell
-15,521
Closed -$221K – 1385
2023
Q2 		$221K Buy
15,521
+5,252
+51% +$73.7K 0.02% 899
2023
Q1 		$153K Sell
10,269
-16,287
-61% -$247K 0.02% 1011
2022
Q4 		$395K Buy
+26,556
New +$433K 0.06% 526

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Y-Intercept (HK)'s MD Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Pediatrix Medical (MD) in Q4 2025, closing a stake of 30,620 shares — an estimated $513K sold.

Y-Intercept (HK) first reported a position in MD in Q4 2022 and held it in 7 quarters. The position peaked at $513K in Q3 2025. 299 funds tracked by Wall St. Rank hold MD as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Pediatrix Medical position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 30,620 Pediatrix Medical shares in Q4 2025, an estimated $513K.
  • Y-Intercept (HK) first reported a position in Pediatrix Medical in Q4 2022 and held it in 7 quarters.
  • Y-Intercept (HK)'s Pediatrix Medical position peaked at $513K in Q3 2025.
  • 299 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.